Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business |
Looking for Device Contract Manufacturing Organizations? | |
| ONLINE SURVEY | | Keck Graduate Institute (Claremont, CA) invites you to participate in an online survey on a proposed degree program for science and engineering postdoctoral fellows interested in entering the life science industry. Click here to participate |
| Recommended Events BioEngineering Insights 2009 ------------------------------------- | 
Register Now |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| 
| July 17, 2009 |
| Thanks to Lead SoCalBio Sponsors |  |
| Apply Now to Make a Presentation at the SoCalBio Investor/Partnership Conference | Is your firm an innovative advanced medical technology or biotech company interested in raising capital, partnering your products or technologies, or initiating strategic alliances? If so, apply now for a company presentation slot during the 11th SoCalBio Investor and Partnership Conference on Sep. 17, 2009 at the Loews Hotel in Santa Monica. Send an executive summary |
SoCalBio Events in July | - July 29, 4:00 - 7:00 pm (Ernst & Young's Office in downtown LA)
-
 SoCalBio Networking Forum in Los Angeles : "Bioscience Business Models Beyond the Current Systemic Funding Drought"
|
SoCalBio-Recommended Seminar | 
Presents Branding Biotech Pharma/Biotech Brand StrategyJuly 27, 6:30 - 9:30 pm, at the Skirball Center July 30, 6:30 to 9:30 pm at UCI
 Delivered by Sasha Strauss (photo right), an award-winning speaker and graduate professor of brand strategy at USC, this seminar will review successful biotech, pharma and medical device company techniques for reaching your audiences, motivating sales force and creating clear and powerful brand messaging that clearly answers the question "so what does your company do?" Click here to RSVP |
| New SoCalBio
Member | TAON BIOPHARMA CONSULTING (Thousand Oaks) Provides comprehensive, systematically structured and integrated scientific, technical and risk analysis for biotech and pharma research programs. Contact founder: Dr. Thomas Schulze at 805-338-4773 or send e-mail to: thomas_j_schulze@yahoo.com |
| New SoCalBio Board Member |  SoCalBio Adds Mr. Don Ferrera of Ernst & Young to its Board of Directors The Southern California Biomedical Council is pleased to announce that Mr. Don Ferrera, Coordinating Partner at Ernst & Young's Los Angeles office, has been elected to serve on the Council's Board of Directors. Mr. Ferrera was unanimously elected during the July 9 SoCalBio board meeting which took place at the California Club in downtown Los Angeles.... Read press release |
| Competitiveness |  Amgen, Facing Cheap Generics, Needs a Hit
|
| Preclinical Studies | Advanced Therapeutics & Co Announces New Treatment for Bleeding After Nuclear Exposure The Anaheim-based company announced that
Fibrinoplate-S has shown efficacy in reducing the bleeding in animals exposed to extreme doses of radiation.... Read more |
| Collaboration | ImmunoCellular Therapeutics of Woodland Hills Retains Services of Torrey Pines Institute for Molecular Studies to Evaluate Lead Product Candidate Torrey Pines Institute for Molecular Studies in San Diego, CA will evaluate the immunogenicity of peptides to target cancer stem cells (CSC's) relating to the Company's lead product candidate ICT-121. The evaluation will be conducted by Dr. Clemencia
Pinilla, a specialist in immune response mechanisms and their role in the prevention and cause of human disease with over 100 publications and multiple patents to her credit.... Read more |
| Product Approval | FDA Denies Approval of Watson Pharmaceuticals' Prostate Cancer Drug, Trelstar The U.S. Food and Drug Administration, in a so-called complete response letter, requested clarification on clinical testing, chemistry, manufacturing and controls of the 24-week formulation of the testosterone-suppressing medicine. The agency is also seeking further information on Watson's third-party manufacturing of the injectable drug, the company said.... Read more |
| Personnel | Abraxis BioScience Names Mary Lynne Hedley, Ph.D., Executive Vice President of Operations and Chief Scientific Officer Dr. Hedley most recently served as Executive Vice President of Eisai Corporation of North America following Eisai's acquisition of MGI
PHARMA, INC. where she had served as Executive Vice President and Chief Scientific Officer since 2005... Read more
Abraxis BioScience Appoints Rick Rodgers Chief Financial Officer
Rogers, 42, was MGI Pharma's controller and chief accounting officer until the company was acquired by Japanese drugmaker Eisai Co. in 2008 ... Read more |
About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
 Editor: Ahmed A. EnanySouthern California Biomedical Council (SoCalBio) |
| |
|
